US Broker Ratings

DaVita Inc. (DVA) Stock Analysis: Evaluating the 18.72% Upside Potential for Healthcare Investors

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specializes in providing kidney dialysis services across the United States. The company’s operations are centered..

Chemed Corp (CHE) Stock Analysis: Navigating Healthcare with Strong Revenue Growth and a 6% Upside Potential

Chemed Corp (NYSE: CHE), a notable player in the healthcare sector, operates within the medical care facilities industry in the United States. With a market capitalization..

Henry Schein, Inc. (HSIC) Stock Analysis: Unveiling a 9.33% Upside Opportunity in the Medical Distribution Sector

Henry Schein, Inc. (NASDAQ: HSIC) stands at the forefront of the healthcare sector, specializing in the medical distribution industry. With a market capitalization of $10.01 billion,..

Stryker Corporation (SYK) Stock Analysis: Exploring a 26% Upside Potential Amidst Strong Buy Ratings

Stryker Corporation (NYSE: SYK), a prominent player in the healthcare sector, stands out in the medical devices industry with a market capitalization of $116.27 billion. Headquartered..

Revvity, Inc. (RVTY) Stock Analysis: Navigating Potential in the Diagnostics Sector Amid Mixed Ratings

Revvity, Inc. (RVTY), a prominent player in the healthcare sector, specifically within the Diagnostics & Research industry, has caught the attention of investors with its recent..

DexCom, Inc. (DXCM) Stock Analysis: A Strong Buy with 7% Upside Potential

DexCom, Inc. (NASDAQ: DXCM), a prominent player in the healthcare sector, is catching the eye of investors as it continues to innovate in the medical devices..

Exelixis, Inc. (EXEL) Stock Analysis: A Promising Biotech with Robust Revenue Growth and Strategic Partnerships

Exelixis, Inc. (NASDAQ: EXEL) has carved out a significant niche in the biotechnology sector, focusing on innovative cancer treatments. Headquartered in Alameda, California, Exelixis is renowned..

Solventum Corporation (SOLV) Stock Analysis: Unlocking Growth Potential in the Healthcare Sector

Solventum Corporation (SOLV), a key player in the healthcare industry, stands poised for growth with its diversified portfolio of medical solutions spanning Medsurg, Dental Solutions, and..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Cincinnati, Ohio, Medpace..

Viatris Inc. (VTRS) Stock Analysis: Evaluating the Healthcare Giant’s 9.60% Potential Upside for Investors

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, stands out as a compelling investment opportunity with a notable potential upside of 9.60%. Headquartered..

West Pharmaceutical Services (WST) Stock Analysis: Unveiling a Potential 19% Upside in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market..

CVS Health Corporation (CVS) Stock Analysis: Exploring a Potential 19.95% Upside for Investors

Investors eyeing opportunities within the healthcare sector might find CVS Health Corporation (NYSE: CVS) an intriguing prospect. With a substantial market capitalization of $123.73 billion, CVS..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A 30% Upside Potential Beckons Investors

Intuitive Surgical, Inc. (NASDAQ: ISRG), a leader in the healthcare sector specializing in medical instruments and supplies, presents a compelling opportunity for investors. With a market..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A 39% Upside Potential Amid Robust Revenue Growth

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, has been capturing investor attention with its innovative approach to therapeutics based on ribonucleic acid..

Incyte Corporation (INCY) Stock Analysis: Riding High on a 37.7% Revenue Growth Surge

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology industry, is captivating investor attention with its robust revenue growth and a promising pipeline of therapeutics...

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: 37% Upside Potential Amid Robust Revenue Growth

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leading biotechnology company based in San Rafael, California, is captivating investor interest with its focus on developing and commercializing therapies..

Waters Corporation (WAT) Stock Analysis: Revenue Growth Surges 113.4%, Analyst Ratings Favorable

Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector, continues to capture the attention of investors with its impressive revenue growth and favorable analyst..

BeOne Medicines Ltd. (ONC) Stock Analysis: Unveiling a 20% Upside Potential in the Biotech Sector

In the ever-dynamic landscape of biotechnology, BeOne Medicines Ltd. (NASDAQ: ONC) has emerged as a promising entity, creating buzz among investors with its robust pipeline and..

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating Growth with a 14% Upside Potential

Fresenius Medical Care AG (NYSE: FMS) stands as a pivotal player in the healthcare sector, specializing in dialysis services and products critical for individuals battling renal..

Sanofi (SNY) Stock Analysis: Navigating a 21% Upside Potential Amidst Robust Revenue Growth

Sanofi (SNY), a global leader in the healthcare sector, is a powerhouse in the drug manufacturing industry. With a substantial market capitalization of $106.01 billion, this..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds